原文开头
A VIRUS has stopped pancreatic cancer in its tracks in three people in a clinical trial in the US. Further evaluation is needed in larger trials, but the early results are encouraging, especially since only small doses of the virus were administered for initial safety testing. The first patient in the trial, who had a pancreatic tumour 7 centimetres across, was administered the treatment a year ago, and the other two have been since then. At the time, their tumours hadn’t spread beyond the pancreas. Since being treated, their tumours haven’t grown any The virus is an adenovirus that has been genetically engineered to replicate only inside tumours. …
摘自《新科学家》(New Scientist)第270卷 第3598期 · 2026年6月6日,Alex Wilkins。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。